Expect recovery in India business in the near term

Glenmark Pharma Q2 Review - Muted Show In India, U.S., Higher Interest Cost Drags Earnings: Motilal Oswal

Here are the stocks to watch before going into trade today.

Stocks To Watch: Coal India, ONGC, Glenmark Pharma, LIC, Grasim Industries, Eicher Motors, SAIL, Biocon

Glenmark Pharma Q2 Results: Incurs Loss Of Rs 62 Crore

Drug-maker Glenmark Pharmaceuticals’ Apremilast Tablets, 10 mg, 20 mg and 30 mg, a generic version of Amgen’s Otezla Tablets, 10 mg, 20 mg and 30 mg, has received final approval from the United States Food and Drug Administration.

Glenmark Pharma’s generic drug to treat psoriatic arthritis gets U.S. FDA approval

The company’s unit has licensed its immunology portfolio with Astria Therapeutics for global development and commercialisation.

Glenmark Pharma’s Biotech Arm Licences Its Immunology Portfolio For Rs 2,700 Crore

S&P revised its outlook to ‘positive’ from ‘stable’ as the stake sale in its lifescience unit will strengthen its financials

Glenmark Pharma Shares Surge 10% On S&P Rating Outlook Upgrade

The pharma company will sell a 75% stake in Glenmark Life Sciences at Rs 615 apiece, lowering the stake to 7.84% after the sale.

Glenmark Pharma Shares Fall As It Plans To Sell Life Sciences Business

Glenmark Pharma - Life Sciences Unit Stake Sale To Drive Considerable De-Leverage: Motilal Oswal

Glenmark Pharma divests 75% stake in Glenmark Life Sciences to Nirma for Rs 5,651 crore.

CMD Glenn Saldanha addresses the media. #BQLive

--------------------------------------------------------------------------------------------------------------------
For more videos subscribe to our channel: http://bit.ly/32JXa74
Visit BQ Prime for more news: https://www.bqprime.com/
Don't enter the stock market unaware. Read all Research Reports here: https://www.bqprime.com/research-reports

For the latest business news and analysis
Subscribe to our Newsletters here: https://www.bqprime.com/my-bq/newsletter
Subscribe to our Telegram channel: https://t.me/BQPrime

Follow BQ Prime here
Twitter: https://twitter.com/bqprime
Facebook: https://www.facebook.com/BQPrime/
LinkedIn: https://www.linkedin.com/company/13184554/
Instagram: https://www.instagram.com/bqprime/
Pinterest: https://in.pinterest.com/BQPrimeNews/

Glenmark Pharma To Sell 75% Stake In Glenmark Life | BQ Prime

Glenmark Pharmaceuticals has entered a three-year deferred prosecution agreement with U.S. DOJ to resolve court proceedings related to pricing of drug pravastatin. Company must adhere to terms, incl. payment of $30M in six instalments, for DOJ to dismiss pending indictment. Glenmark committed to eth…

Glenmark settles drug pricing case with U.S. Department of Justice

Glenmark Pharmaceuticals Inc., USA on Tuesday announced that it has entered into an agreement with the U.S. Department of Justice, Antitrust Division (DOJ) to resolve all of its court proceedings with the DOJ involving historical pricing practices by former employees relating to the generic drug pravastatin between 2013 and 2015. 

Ekta Batra with the details.


#glenmarkpharma #DoJsettlement #pricefixingcharges #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday   
 
🔴CNBC TV18 LIVE TV: https://youtube.com/live/P857H4ej-MQ
SUBSCRIBE to our Channel: https://bit.ly/3nvEcxf
---------------------------------------------------------------------------------------------------------------------
                               👑 Check Out Top CNBC TV18 Playlist Videos: 

🔹CNBC TV18 Classic Interviews: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDmfXVg7XEQngsCY9RoS-fv

🔹CNBC TV18 Digital: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDCcaVZ_82M9vhLo9lGJYzo

🔹CNBC TV18 Weekend Special: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBHEa5NnoKuUsX5GwxEGuri

🔹CNBC TV18 Next-Gen: https://www.youtube.com/playlist?list=PLjq9mRS1PfGA6roe9q3J9fq_gBIDjX2w7

🔹Overdrive Show: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCnSVjfbWfNCJLrv-CqfGmH
🔹CNBC TV18 Newsreels: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCmABWWQRX4NqGLCtScwqex

🔹Young Turks: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBZaN1e38X2ZmevnU1e1NJs

🔹Startup Streets: https://www.youtube.com/playlist?list=PLjq9mRS1PfGD3CzrtMr_VJRbIly6sfyFI

------------------------------------------------------------------------------------
You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/

You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/

Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News
Follow us on Instagram: https://www.instagram.com/cnbctv18india/
Catch us on: Linkedin: https://in.linkedin.com/company/cnbc-tv18
n18oc_business

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.

Glenmark Pharma Reaches Anti-Trust Settlement With U.S. DoJ To Resolve Price Fixing Charges

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Glenmark Pharmaceuticals Limited is a global pharmaceutical company engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs).